​​​​Luxena Pharmaceuticals, Inc. © ALL RIGHTS RESERVED

Company Overview

Luxena Pharmaceuticals, Inc. was founded in July 2013 by experienced drug developers in pharmaceutical industry with proven track-record of regulatory successes.  The business goal of Luxena is to develop innovative products of low regulatory risks and high market potentials. Luxena is building up a diversified portfolio of product candidates that are synergistic to each other.  The pipeline portfolio includes redesigned formulations of widely used drugs for novel delivery.  The company’s current lead product (LPI-1503) is to prevent and eliminate nausea and vomiting that are induced by chemotherapy, radiotherapy or surgery.